/ /

In partnership with the Dermatology Education Foundation, view featured articles from Dermatology Times with expert NP and PA commentary.

Derm NP and PA Resource Center

May Clinical Considerations for NPs, PAsThis month, we take a look at a treatment approach to hidradenitis suppurativa, the impact of atopic dermatitis on pediatric patients and a way to prevent mycosis fungoides progression.
April Clinical Considerations for NP's, PAsIn this month's Clinical Considerations, we look at handling the difficult patient, how to improve our diagnostic skills and the latest psoriasis drug approval.
March Clinical Considerations for NPs, PAsThis month we’re looking at some allergy guideline recommendations, discuss whether or not ‘natural’ soap is milder and novel immunomodulaters.
February Clinical Considerations for NPs, PasIn our February Clinical Considerations, we take a look at treatment options for a few common skin disorders.
January Clinical Considerations for NPs, PAsThis month, we take a look at when to use biologics, advances in pediatric Atopic Dermatitis (AD), and how Trump’s presidency might impact dermatology.
How the Trump presidency may impact dermatologyDermatology’s leaders share perspectives on how the new Administration may impact medicine.
December Clinical Considerations for NPs, PAsIn this month's Clinical Considerations, we take a look at AD and bullying, whether or not derms are doing enough for psoriasis patients, and the potential of Epicutaneous immunotherapy.
Pearls to optimize safety, success with biologicsOne dermatologist describes his considerations for choosing a biologic to treat a patient with moderate-to-severe psoriasis, baseline assessments, and follow-up approach.
November Clinical Considerations for NPs, PAsIn this month's Clinical Considerations, we take a look at a few specific disorders and how to properly diagnose and treat them in our patients.
Study offers new insight into pediatric eczema
Study offers new insight into pediatric eczemaResearchers have identified the skin phenotype of pediatric atopic dermatitis (AD) — a finding that challenges the notion of filaggrin's central role in the disease.